Suppr超能文献

异种人类淋巴细胞在无胸腺裸鼠中的存活及组织定位:对正常受试者和多发性硬化症患者的观察

Survival and tissue localization of xenogeneic human lymphocytes in hypothymic nude mice: observations in normal subjects and multiple sclerosis.

作者信息

Bernard C C, Mackay I R

出版信息

Clin Exp Immunol. 1984 Jan;55(1):211-6.

Abstract

The feasibility of using the hypothymic nude mouse as a transfer system for the study of cellular autoimmunity, by injection and tracing of 51chromium (Cr) or fluorescein labelled lymphocytes from humans, allogeneic or syngeneic mice was investigated. The localization of the injected cells was studied by radioisotopic counting or microscopy. For mouse cells there was better survival of syngeneic than allogeneic cells, and the pattern of distribution of injected mouse lymphocytes differed markedly from that of xenogeneic human lymphocytes. Thus, the lymph nodes and spleen were the predominant sites of localization of transferred syngeneic (BALB/c) lymphocytes, indicative of long recirculation of these cells, whereas the liver was the predominant site of localization of transferred human lymphocytes, and there was no evidence for recirculation of these cells. In studies on patients with multiple sclerosis, lymphocytes did not localize in neural tissue. The data indicate that the nude mouse is unlikely to be useful for the study of the tissue distribution of dispersed xenogeneic (human) lymphocytes.

摘要

通过注射和追踪来自人类、同种异体或同基因小鼠的51铬(Cr)或荧光素标记的淋巴细胞,研究了将下丘脑性裸鼠用作细胞自身免疫研究的转移系统的可行性。通过放射性同位素计数或显微镜检查研究注射细胞的定位。对于小鼠细胞,同基因细胞比异基因细胞具有更好的存活率,并且注射的小鼠淋巴细胞的分布模式与异种人类淋巴细胞的分布模式明显不同。因此,淋巴结和脾脏是转移的同基因(BALB/c)淋巴细胞的主要定位部位,表明这些细胞有较长时间的再循环,而肝脏是转移的人类淋巴细胞的主要定位部位,并且没有证据表明这些细胞有再循环。在对多发性硬化症患者的研究中,淋巴细胞未定位在神经组织中。数据表明,裸鼠不太可能用于研究分散的异种(人类)淋巴细胞的组织分布。

相似文献

本文引用的文献

9
Acute experimental autoimmune encephalomyelitis: T- and B-cell distribution within the target organ.
Cell Immunol. 1982 Jul 1;70(2):345-56. doi: 10.1016/0008-8749(82)90335-5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验